Nanobiotix S.A.
EPA:NANO.PA
Overview | Financials
Company Name | Nanobiotix S.A. |
Symbol | NANO.PA |
Currency | EUR |
Price | 3.954 |
Market Cap | 186,277,614 |
Dividend Yield | 0% |
52-week-range | 3.816 - 7.93 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Laurent Levy Ph.D. |
Website | https://www.nanobiotix.com |
An error occurred while fetching data.
About Nanobiotix S.A.
Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD